Want to join the conversation?
$PFE 2Q15 PR: For the third consecutive quarter, the company saw operational revenue growth, excluding the impact of ForEx and despite LOE headwinds. Compared to 2Q14, Eliquis alliance revenues nearly tripled on a global basis and Xeljanz revenues nearly doubled. Prevenar 13 revenue in the US increased 87%.
$MON shares dip slightly; I wonder this is because of the environmental lawsuit filed by the Washington state against the production of PCBs.
My bet is that $FR will reach $32 in the short term. It’s time it broke the 52-week high and had its fair share of growth.
$WYNN got bruised up by China after its decision to cut withdrawal limit in Macau ATMs. Wynn Resorts shares went down by more than 11%! Well who could have guessed that right?